The Bulletin
Times Advertising


.

CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial

  • Written by PR Newswire

Read more http://www.prnasia.com/story/archive/4888475_CN88475_0